MISSISSAUGA, ON, Aug. 5, 2022 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its Q2 2022 financial results on Thursday, August 11, 2022 after market close. The Company will also host a conference call on Friday, August 12, 2022 at 8:30am ET to discuss the results and corporate developments.  

CONFERENCE CALL DETAILS

DATE:

August 12, 2022


TIME:

8:30 a.m. ET


DIAL-IN NUMBER:

(647) 484-0475 or (888) 220-8451


CONFERENCE ID:

7538758


REPLAY DIAL-IN:

(888) 203-1112 (playback 7538758#)

Expires August 19, 2022


WEBCAST:   

https://app.webinar.net/871ZpObNzYX

 

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.

Copyright 2022 Canada NewsWire

Cipher Pharmaceuticals (TSX:CPH)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Cipher Pharmaceuticals Charts.
Cipher Pharmaceuticals (TSX:CPH)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Cipher Pharmaceuticals Charts.